CCI clears Mankind Pharma’s Rs 13,630 crore deal

NEW DELHI: The

CCI

approved the proposed acquisition of Bharat Serums and Vaccines by Mankind

Pharma

for Rs 13,630 crore.

Mankind

develops, manufactures, and

markets

a range of pharmaceutical finished dosage formulations.